MARKET

XRTX

XRTX

Xortx Therapeutics Inc
NASDAQ
2.050
-0.050
-2.38%
Closed 16:00 06/24 EDT
OPEN
2.100
PREV CLOSE
2.100
HIGH
2.105
LOW
2.050
VOLUME
1.94K
TURNOVER
0
52 WEEK HIGH
7.52
52 WEEK LOW
1.900
MARKET CAP
5.95M
P/E (TTM)
-1.4581
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at XRTX last week (0617-0621)?
Weekly Report · 22h ago
Weekly Report: what happened at XRTX last week (0610-0614)?
Weekly Report · 06/17 11:07
Xortx Therapeutics Inc: Prospectus [Rule 424(b)(3)]
Press release · 06/14 02:07
XORTX Therapeutics Plans Major Warrant Repricing
TipRanks · 06/12 11:49
Weekly Report: what happened at XRTX last week (0603-0607)?
Weekly Report · 06/10 11:09
XORTX Therapeutics Showcases Progress at BIO 2024
TipRanks · 06/04 12:58
Weekly Report: what happened at XRTX last week (0527-0531)?
Weekly Report · 06/03 11:12
Weekly Report: what happened at XRTX last week (0520-0524)?
Weekly Report · 05/27 11:16
More
About XRTX
XORTX Therapeutics Inc. is a Canada-based late-stage clinical pharmaceutical company. The Company develops therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications, such as autosomal dominant polycystic kidney disease (ADPKD), as well as type 2 diabetic nephropathy (T2DN) and fatty liver disease. It is working to advance its clinical development stage products that target aberrant purine metabolism and xanthine oxidase to decrease or inhibit production of uric acid. The Company has three product development programs: XRx-008, which is a program for the treatment of ADPKD; XRx-101, which is a program to treat acute kidney injury (AKI) associated with respiratory virus infection, AKI and associated health consequences, and XRx- 225, a program for the treatment of T2DN. The Company's XRx-008 program is designed for longer term stable chronic oral dosing of xanthine oxidase inhibitors.

Webull offers XORTX Therapeutics Inc stock information, including NASDAQ: XRTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XRTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading XRTX stock methods without spending real money on the virtual paper trading platform.